Compliance, competition could be speed breakers
As India positions itself as part of the China+plus one strategy, China has a counter strategy: dumping of low cost imports and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indian pharma
Govt bans 156 FDCs with immediate effect
The notification by the Central Government stated “the said Expert Committee considered this FDC as irrational”
An open letter: Concerns on electoral bonds and pharma industry
Chandru Chawla, a pharma veteran writes an open letter to those CEOs of Pharmaceutical companies who have NOT purchased Electoral…
Building resilience and rethinking strategies for growth: Pharma in focus
Mukesh Khare, Partner & Head-India Operations, Kaizen Institute highlights that aspiring to become a hub for cost-effective…
One of the game-changers with CPHI is its ability to draw global players into India
An Express Pharma exclusive with Olga PonomarevaStepnaya, Brand Manager, CPHI India, on trends and challenges in pharma sector,…
What UPI did to consumers and businesses, UPHI will do to healthcare
Suresh Subramanian, Partner, National Life Sciences Leader at EY India speaks on making India Pharma Inc more 'value-driven' and…
We are in a better shape to handle any untoward circumstances
Ravi Udaya Bhaskar, Director-General, Pharmexcil, shares the scenario of pharma imports and exports, and the role played by…
Indian pharma industry likely to reach $100-bn and medical devices sector reach $50-bn by 2025 : D V…
He spoke at the India Pharma and India Medical Device 2020 event where FICCI-EY report ‘Reshaping India into a life sciences…